Drugs / CAR-ITNK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04747093 | Jan → Dec 2021 | B-cell acute lymphoblastic leukemia | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-ITNK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04747093 ↗ |